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Background: Over the past 15 years, repeated national meetings have developed recommendations for a
Canadian antimicrobial resistance strategy. Despite this, in 2011 there is no comprehensive, integrated national
program with appropriate governance and funding to address antimicrobial resistance.
Findings: The Public Health Agency of Canada supports a reference laboratory for diagnosis and characterization
of selected resistant strains, targeted surveillance programs which monitor resistance trends for selected animal
and human organisms, development of national infection control guidelines including for antimicrobial resistant
organisms, and a few local pilot projects to address community acquired MRSA. Sporadic programs of variable
intensity and quality are supported by some provinces, health regions and individual facilities but these are not
comprehensive, standardized or integrated. Individual researchers and research groups, however, have published
substantial information describing the prevalence and impact of resistance in Canada.
Conclusions: Current review of activities by the Public Health Agency of Canada and initiatives by the National
Coordinating Centre for Infectious Diseases may move the country forward in developing an effective national
approach to address antimicrobial resistance.
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Background
Over the past 15 years, the problem of antimicrobial
resistance in Canada has been repeatedly discussed at
national meetings, with recommendations developed to
address this problem in the Canadian context. Some key
documents from these meetings are:
1. Consensus Conference: Controlling antimicrobial
resistance: An integrated action plan for Canadians
(1997) [1]. http://www.phac-aspc.gc.ca/publications-
eng.php#C
2. Uses of Antimicrobials in Food Animals in
Canada: Impact on Resistance and Human Health.
Report of the Advisory Committee on Resistance
and Human Health (2002) [2]. http://www.hc-sc.gc.
ca/dhp-mps/pubs/vet/amr-ram_final_report-rap-
port_06-27cp-pc-eng.php
3. Proposed National Action plan to Combat Anti-
microbial Resistance. Canadian Committee on Anti-
microbial Resistance (2004).
4. The Pan-Canadian Stakeholder Consultations on
Antimicrobial Resistance, Canadian Committee on
Antibiotic Resistance (2009).
5. Consultation: Community acquired antimicrobial
resistance, National Collaborating Centre for Infec-
tious Diseases (2010). http://www.nccid.ca
However, despite universal acknowledgment that anti-
microbial resistance is an important Canadian problem
together with consistent interest in addressing the issue
at a national level, in 2011 there is no comprehensive,
integrated, national Canadian program with appropriate
governance and funding for limiting the progression of
antimicrobial resistance.
Activities
The Canadian Committee on Antibiotic Resistance was
established after the 1997 Consensus Conference to co-
ordinate and provided leadership for antimicrobial
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resistance initiatives in Canada. It functioned until 2009,
spearheading a number of initiatives, when it was dis-
solved after funding was discontinued. The Public
Health Agency of Canada currently supports a reference
laboratory for diagnosis and characterization of resistant
bacterial strains, as well as targeted surveillance pro-
grams to monitor resistance trends for selected animal
and human pathogens, development of national infec-
tion control guidelines including for management of
antimicrobial resistant organisms in health care facilities,
and some pilot projects to address community acquired
MRSA. Programs of variable intensity and quality are
also supported by some individual provinces, health
regions and health care facilities, but these are not com-
prehensive, standardized or integrated. Individual
researchers and research groups have published substan-
tial information which describes the prevalence and
impact of antimicrobial resistance in Canada. These stu-
dies consistently report that the prevalence of antimicro-
bial resistance in bacterial isolates from Canada tends to
be lower than reported for the United States, but that
trends over time, with few exceptions (fluoroquinolone
resistant S. pneumoniae), are to increasing resistance.
Successes
While there has been limited progress towards a com-
prehensive national program, some unique programs to
address selected aspects of antimicrobial resistance have
been developed and maintained. These programs
include:
1. “Do Bugs need Drugs” http://www.dodrugsneed-
bugs.org
A community based public and professional education
program promoting handwashing and responsible use of
antibiotics to address the problem of antimicrobial resis-
tance. Programs are available for physicians ("Bugs and
Drugs” Antimicrobial Indications Handbook), pharma-
cists, nurses, occupational health nurses, teachers,
schools, daycare centres, assisted living centres, parents,
children and the public. This program was initially
developed with government support in the province of
Alberta, and subsequently introduced into a second pro-
vince, British Columbia. Selected program components
are also used in some other jurisdictions in Canada.
Evaluation of the impact of the program or individual
program components on community antimicrobial resis-
tance has not, however, been reported.
2. Northern Antibiotic Resistance Partnership http://
www.Germsaway.ca
This community, federal government, and academic
partnership has used a public health approach to
develop guidelines and teaching materials for prevention
and management of CA-MRSA infections in isolated
northern communities, many of which have a very high
incidence of infections with these organisms. The pro-
gram includes an interactive video game for schools, an
educational tool, handwashing posters aimed at children,
slide presentations, education podcasts, radio broadcasts
in English and local Aboriginal languages, and CA-
MRSA pamphlets for physicians offices and health cen-
tres in the relevant communities. Following the imple-
mentation of the program, a decrease in CA-MRSA
infection in some of the program communities has been
observed, but the extent to which this can be attributed
to the program activities is not determined.
3. Canadian Nosocomial Infection Surveillance Pro-
gram (CNISP) http://www.phac-aspc.gc.ca/nois-sinp/
survprog-eng.php
This partnership between AMMI-Canada (Association
of Medical Microbiology and Infectious Diseases -
Canada) and the Public Health Agency of Canada was
initially established in 1994. It currently supports
focused monitoring of healthcare acquired infections,
including selected antimicrobial resistant organisms
(including MRSA [3], VRE [4], C. difficile, resistant
gram negatives), at 37 sentinal hospitals - most of the
Canadian tertiary care centres. Specific projects have
described the prevalence, incidence, trends over time,
and some impacts of antimicrobial resistant organisms
in the Canadian Health Care system.
4. Canadian Integrated Program of Antimicrobial
Resistance Surveillance (CIPARS) http://www.phac-aspc.
gc.ca/cipars-picra/index-eng.php
This program monitors trends in antimicrobial use
and resistance for selected food borne bacterial organ-
isms (E. coli 0157:H7, Salmonella spp, Campylobacter
spp) isolated from humans, agricultural animals, and
food sources across Canada. Surveillance includes results
of cultures collected from abattoirs, animal clinical spe-
cimens, animal feed, human clinical specimens, on-farm,
and retail, as well as of human and animal antimicrobial
use. There are annual reports for 2002 - 2007, prelimin-
ary reports for 2008, 2009, and agrifood quarterly sum-
maries of Salmonella spp (most recent Oct - Dec 2010).
Conclusion
Despite some successes with these and other isolated
activities, it is acknowledged that an integrated, national
antimicrobial resistance policy and program incorporat-
ing an effective governance structure and appropriate
sustained funding is essential to modify the progression
of antimicrobial resistance in Canada and limit potential
negative effects associated with resistance. This must
include a comprehensive national antimicrobial resis-
tance surveillance system and coherent definitions and
programs for antimicrobial stewardship in health care
facilities, the community, animal and environmental set-
tings. Some current activities, it is hoped, may move this
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agenda forward. The Public Health Agency of Canada
has recently reviewed the status of antimicrobial resis-
tance activities within the organization and across
Canada and identified gaps in antimicrobial resistance
activities at the federal agency level. These have been
summarized in the context of surveillance, research, best
practices for limitation and control of resistance, and
governance policy and legislation. The agency has said it
will commit resources internally to develop a specific
focus addressing antimicrobial resistance as a response
to this review. The National Collaborating Centre on
Infectious Diseases has identified community antimicro-
bial resistance as a Centre priority. It spearheaded a dis-
cussion of needs and process to address community
antimicrobial resistance, and also recently issued a
request for applications to critically review current activ-
ities addressing antimicrobial resistance surveillance
across Canada, together with identification of needs to
move forward in developing a relevant, effective national
surveillance program. These initiatives may be helpful, if
sustained, to promote the development of a national
antimicrobial resistance program.
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